Skip to main content

Gadoteridol Pregnancy and Breastfeeding Warnings

Medically reviewed by Last updated on Apr 3, 2023.

Gadoteridol is also known as: Prohance

Gadoteridol Pregnancy Warnings

Gadoteridol has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Gadoteridol is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

See references

Gadoteridol Breastfeeding Warnings

There are no data on the excretion of gadoteridol into human milk. The manufacturer recommends that caution be used when administering gadoteridol to nursing women.

See references

References for pregnancy information

  1. "Product Information. ProHance (gadoteridol)." Bracco Diagnostics Inc (2001):

References for breastfeeding information

  1. "Product Information. ProHance (gadoteridol)." Bracco Diagnostics Inc (2001):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.